Fibrotic Diseases Treatment Market Report and Forecast 2025-2034

Fibrotic Diseases Treatment Market Outlook

The fibrotic diseases treatment market size is expected to grow at a CAGR of 7.8% during the forecast period of 2025-2034. The market is likely to be driven by the rising prevalence and incidence of fibrotic diseases, the growing demand for precision medicine, and heightened patient awareness across the 8 major markets.

Fibrotic Diseases Treatment Market Overview

Fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF) and scleroderma, are characterized by severe organ fibrosis. Progressive fibrosis can result in the thickening or scarring of the tissue. According to a study published in BMC Pulmonary Medicine in February 2023, the rate of idiopathic pulmonary fibrosis (IPF) has been increasing over time. The study found that the yearly prevalence rate of IPF increased from 7.50 to 23.20 per 100,000 individuals, and the yearly incidence rate increased from 3.56 to 7.91 per 100,000 individuals.  The rising number of patients afflicted with this condition will fuel the fibrotic diseases treatment market growth in the forecast period.

In September 2023 , Boehringer Ingelheim initiated the clinical development of its first-of-its-kind IL-11 inhibitor antibody, BI 765423, through a Phase 1 study. The objective of the trial was to evaluate the treatment's safety, tolerance, and pharmacokinetics in fibrotic diseases. According to preclinical studies, anti-IL-11 treatment had the potential to halt and even reverse fibrosis in various fibrotic diseases. To bolster its fibrotic disease portfolio, Boehringer Ingelheim also partnered with Enleofen Bio Pte Ltd, a biotechnology company based in Singapore. The development of promising therapeutics is projected to fuel the fibrotic diseases treatment market demand in the coming years.

Significant drivers for market growth also include the rise in strategic partnerships among the key market players. In addition, the increased healthcare expenditure and growing geriatric population as also expected to contribute to the market value in the forecast period.

Fibrotic Diseases Treatment Market Trends

Fibrotic Diseases Treatment Market Segmentation

Market Breakup by Treatment Type

• Medication

• Organ Transplantation

• Oxygen Therapy

• Others

The market segmentation by treatment type comprises medication, organ transplantation, and oxygen therapy, among others. Medication options aim to slow disease progression and reduce symptoms by targeting inflammation and fibroblast activation. Organ transplantation may be necessary when fibrosis irreversibly damages vital organs. Oxygen therapy helps manage respiratory symptoms in fibrotic lung diseases.

Market Breakup by Applications

• Idiopathic Pulmonary Fibrosis

• Hepatic Cirrhosis

• Renal Fibrosis

• Cutaneous Fibrosis

• Others

On the basis of applications, the fibrotic diseases treatment market share includes idiopathic pulmonary fibrosis (IPF), hepatic cirrhosis, renal fibrosis, cutaneous fibrosis, and others. These diverse applications convey the scope of the treatment market across various organ systems.

Market Breakup by End User

• Hospitals

• Academic and research institutes

• Others

End users of the market are hospitals, academic, and research institutes, among others. Academic and research institutes significantly contribute to the development of innovative treatments and therapeutic approaches.

Market Breakup by Region

• United States

• EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
• Japan

• India

The segmentation based on the region covers the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. North America holds a substantial fibrotic diseases treatment market value which can be attributed to the rising geriatric population base in the region. Moreover, the high prevalence rate of fibrotic diseases and the presence of key market players are also boosting growth in this regional market.

Fibrotic Diseases Treatment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Genentech, Inc.

• Boehringer Ingelheim International GmbH

• AbbVie Inc.

• Bristol-Myers Squibb Company

• BellBrook Labs

• Enveda Biosciences

• Gilead Sciences, Inc.

• KITHER BIOTECH S.R.L.

• Verona Pharma plc

• Alpine Immune Sciences 

• Intercept Pharmaceuticals, Inc.

• Teva Pharmaceutical Industries Ltd.

• Sandoz International GmbH

• Accord Healthcare

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Key Queries Solved in the Fibrotic Diseases Treatment Market Report

• What are the emerging trends and developments shaping the future of the fibrotic diseases treatment market?
• Which treatment option dominates the market segment?
• What factors are driving or restraining the growth of the market?
• How is the market segmented by applications, end-users, and geographic regions?
• What are the pipeline developments and emerging therapies in the fibrotic diseases treatment market?
• How is the prevalence of fibrotic diseases projected to change in the future?
• Which is the most common fibrotic disease in terms of prevalence and how will it impact the market size?
• What key research initiatives will propel fibrotic diseases treatment market size during the forecast period? 
• What are the unmet needs and opportunities in the market?
• Which country is poised to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• Which applications of the treatment market are expected to significantly impact the growth of the market?
• Which segment will have the highest impact on the market size in the coming years? 
• How are academic and research institutes contributing to advancements in fibrotic diseases treatment?
• How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?